Earnings calendar

Teva Pharmaceutical Industries Limited (TEVA) earnings: date, estimates, results and stock reactions

Next earnings: Q4 FY2026 on 2027-02-10 (expected, before the open). EPS estimate 2.16, revenue estimate 13.87B.

Over the last 12 reports the stock moved 8.3% on average (either way), rising 10 times and falling 2. EPS beat estimates 10 of 12 times; revenue 10 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q3 FY20262026-11-032.732.22+23.0%13.67B13.02B+0.8%
Q2 FY20262026-07-290.060.16-60.7%12.75B12.14B+11.4%
Q1 FY20262026-04-291.471.43+2.8%11.84B11.47B+10.8%
Q4 FY20252026-01-282.901.98+46.5%14.59B13.63B+2.1%
Q3 FY20252025-11-052.502.23+12.1%14.36B14.34B+17.8%
Q2 FY20252025-07-302.242.10+6.7%14.15B14.47B+0.6%
Q1 FY20252025-05-071.771.61+9.9%13.96B14.66B+6.6%
Q4 FY20242025-01-292.552.43+4.9%15.21B14.91B-19.6%

TEVA stock report · Earnings calendar